Haemonetics issues Q4 FY2022 earnings press release; details not available in filing text

HAEMONETICS CORP

2022-FY EPS reported $0.84 revenue$993,196,000

Press release dated May 10, 2022, furnished as Exhibit 99.1, covers Q4 and full year ended April 2, 2022.
Specific financial results (revenue, EPS, guidance) are not included in the 8-K or appended exhibit text provided.
No material updates beyond the fact of the earnings release can be confirmed from the filing alone.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.